Tag: diabetic macular edema (DME)

23-EYE-3521610 CQD-Time to resolution of DME-Talcott-650×450
February 8, 2023/Diabetes & Endocrinology

Diabetic Macular Edema Can Take 1-2 Years to Resolve in Patients Despite Aggressive Treatment

Greater central subfield thickness and better visual acuity at baseline are associated with longer time to resolution

21-EYE-2172358-CQD-Rachitskaya

Even Brief Delays in Intravitreal Injection Can Cause Vision Loss

Patients with diabetic eye disease are most affected

20-EYE-1961371-CQD-AI-radiomics-in-diabetic-eye-disease-Hero

Retinal Leakage Pattern and Vascular Tortuosity May Predict Durability of Anti-VEGF Therapy

Radiomics analysis suggests underlying subvisual features may encode information related to tolerance of interval extension in retinal vascular disease

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-EYE-1964900-Lapse-in-AMD-and-DME-treatment-Hero

Consequences of Lapse in Anti-VEGF Therapy During the COVID-19 Pandemic

Studies evaluate patients who missed treatments for diabetic macular edema and neovascular age-related macular degeneration

18-EYE-4207-DRIL-CQD-Feat

Predicting Visual Acuity Response to Anti-VEGF Therapy in Macular Edema Secondary to Retinal Vein Occlusion

Is disorganization of retinal inner layers (DRIL) a useful prognostic indicator?

18-EYE-1206-Singh-CQD-1

Advancing Insights into Diabetic Eye Disease

Despite significant progress, questions remain

BackPage 1 of 1Next

Advertisement

Ad